250 related articles for article (PubMed ID: 17587825)
1. Vimentin and epithelial-mesenchymal transition in human breast cancer--observations in vitro and in vivo.
Kokkinos MI; Wafai R; Wong MK; Newgreen DF; Thompson EW; Waltham M
Cells Tissues Organs; 2007; 185(1-3):191-203. PubMed ID: 17587825
[TBL] [Abstract][Full Text] [Related]
2. Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells.
Steinmetz NF; Cho CF; Ablack A; Lewis JD; Manchester M
Nanomedicine (Lond); 2011 Feb; 6(2):351-64. PubMed ID: 21385137
[TBL] [Abstract][Full Text] [Related]
3. Vimentin in cancer and its potential as a molecular target for cancer therapy.
Satelli A; Li S
Cell Mol Life Sci; 2011 Sep; 68(18):3033-46. PubMed ID: 21637948
[TBL] [Abstract][Full Text] [Related]
4. Vimentin regulates EMT induction by Slug and oncogenic H-Ras and migration by governing Axl expression in breast cancer.
Vuoriluoto K; Haugen H; Kiviluoto S; Mpindi JP; Nevo J; Gjerdrum C; Tiron C; Lorens JB; Ivaska J
Oncogene; 2011 Mar; 30(12):1436-48. PubMed ID: 21057535
[TBL] [Abstract][Full Text] [Related]
5. Expression of vimentin in breast carcinoma, its correlation with Ki67 and other histopathological parameters.
Hemalatha A; Suresh TN; Kumar ML
Indian J Cancer; 2013; 50(3):189-94. PubMed ID: 24061457
[TBL] [Abstract][Full Text] [Related]
6. Cytokeratin and vimentin expression in breast cancer.
Vora HH; Patel NA; Rajvik KN; Mehta SV; Brahmbhatt BV; Shah MJ; Shukla SN; Shah PM
Int J Biol Markers; 2009; 24(1):38-46. PubMed ID: 19404921
[TBL] [Abstract][Full Text] [Related]
7. Vimentin induces changes in cell shape, motility, and adhesion during the epithelial to mesenchymal transition.
Mendez MG; Kojima S; Goldman RD
FASEB J; 2010 Jun; 24(6):1838-51. PubMed ID: 20097873
[TBL] [Abstract][Full Text] [Related]
8. The role of vimentin intermediate filaments in the progression of lung cancer.
Kidd ME; Shumaker DK; Ridge KM
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):1-6. PubMed ID: 23980547
[TBL] [Abstract][Full Text] [Related]
9. The epithelial to mesenchymal transition in pancreatic cancer: A systematic review.
Beuran M; Negoi I; Paun S; Ion AD; Bleotu C; Negoi RI; Hostiuc S
Pancreatology; 2015; 15(3):217-25. PubMed ID: 25794655
[TBL] [Abstract][Full Text] [Related]
10. Vimentin contributes to epithelial-mesenchymal transition cancer cell mechanics by mediating cytoskeletal organization and focal adhesion maturation.
Liu CY; Lin HH; Tang MJ; Wang YK
Oncotarget; 2015 Jun; 6(18):15966-83. PubMed ID: 25965826
[TBL] [Abstract][Full Text] [Related]
11. The basics of epithelial-mesenchymal transition.
Kalluri R; Weinberg RA
J Clin Invest; 2009 Jun; 119(6):1420-8. PubMed ID: 19487818
[TBL] [Abstract][Full Text] [Related]
12. Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation.
Chaw SY; Abdul Majeed A; Dalley AJ; Chan A; Stein S; Farah CS
Oral Oncol; 2012 Oct; 48(10):997-1006. PubMed ID: 22704062
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-mesenchymal transitions in development and disease.
Thiery JP; Acloque H; Huang RY; Nieto MA
Cell; 2009 Nov; 139(5):871-90. PubMed ID: 19945376
[TBL] [Abstract][Full Text] [Related]
14. Vimentin: Central hub in EMT induction?
Ivaska J
Small GTPases; 2011 Jan; 2(1):51-53. PubMed ID: 21686283
[TBL] [Abstract][Full Text] [Related]
15. Vimentin as an integral regulator of cell adhesion and endothelial sprouting.
Dave JM; Bayless KJ
Microcirculation; 2014 May; 21(4):333-44. PubMed ID: 24387004
[TBL] [Abstract][Full Text] [Related]
16. Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.
Lindsey S; Langhans SA
Front Oncol; 2014; 4():358. PubMed ID: 25566498
[TBL] [Abstract][Full Text] [Related]
17. Snail promotes epithelial mesenchymal transition in breast cancer cells in part via activation of nuclear ERK2.
Smith BN; Burton LJ; Henderson V; Randle DD; Morton DJ; Smith BA; Taliaferro-Smith L; Nagappan P; Yates C; Zayzafoon M; Chung LW; Odero-Marah VA
PLoS One; 2014; 9(8):e104987. PubMed ID: 25122124
[TBL] [Abstract][Full Text] [Related]
18. Vimentin, zeb1 and Sip1 are up-regulated in triple-negative and basal-like breast cancers: association with an aggressive tumour phenotype.
Karihtala P; Auvinen P; Kauppila S; Haapasaari KM; Jukkola-Vuorinen A; Soini Y
Breast Cancer Res Treat; 2013 Feb; 138(1):81-90. PubMed ID: 23412770
[TBL] [Abstract][Full Text] [Related]
19. [Role of vimentin in cell migration].
Chernoivanenko IS; Minin AA; Minin AA
Ontogenez; 2013; 44(3):186-202. PubMed ID: 23885566
[TBL] [Abstract][Full Text] [Related]
20. E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.
Araki K; Shimura T; Suzuki H; Tsutsumi S; Wada W; Yajima T; Kobayahi T; Kubo N; Kuwano H
Br J Cancer; 2011 Dec; 105(12):1885-93. PubMed ID: 22068819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
